Your browser is no longer supported. Please, upgrade your browser.
LMAT LeMaitre Vascular, Inc. weekly Stock Chart
LMAT [NASD]
LeMaitre Vascular, Inc.
Index- P/E48.67 EPS (ttm)0.60 Insider Own18.30% Shs Outstand18.75M Perf Week0.52%
Market Cap547.50M Forward P/E36.00 EPS next Y0.81 Insider Trans-7.80% Shs Float14.78M Perf Month2.28%
Income11.60M PEG3.24 EPS next Q0.17 Inst Own64.40% Short Float3.51% Perf Quarter15.10%
Sales93.00M P/S5.89 EPS this Y29.90% Inst Trans0.92% Short Ratio2.51 Perf Half Y26.52%
Book/sh4.92 P/B5.93 EPS next Y15.86% ROA11.50% Target Price30.57 Perf Year104.48%
Cash/sh1.38 P/C21.22 EPS next 5Y15.00% ROE13.40% 52W Range14.04 - 33.22 Perf YTD15.23%
Dividend0.22 P/FCF49.77 EPS past 5Y32.60% ROI12.20% 52W High-12.88% Beta0.64
Dividend %0.75% Quick Ratio4.10 Sales past 5Y9.10% Gross Margin70.90% 52W Low106.13% ATR1.30
Employees397 Current Ratio5.80 Sales Q/Q18.70% Oper. Margin18.50% RSI (14)46.14 Volatility2.63% 3.77%
OptionableYes Debt/Eq0.00 EPS Q/Q42.20% Profit Margin12.50% Rel Volume0.52 Prev Close29.20
ShortableYes LT Debt/Eq0.00 EarningsJul 27 AMC Payout28.70% Avg Volume206.81K Price28.94
Recom2.40 SMA20-3.57% SMA50-3.54% SMA20014.83% Volume17,980 Change-0.89%
Jul-10-17Downgrade The Benchmark Company Buy → Hold
Jul-10-17Downgrade Canaccord Genuity Buy → Hold $28
Mar-21-17Initiated First Analysis Sec Overweight $29
Feb-22-17Downgrade Barrington Research Outperform → Mkt Perform
Sep-22-16Downgrade Sidoti Buy → Neutral
Jul-28-16Reiterated Barrington Research Outperform $18.50 → $20
Feb-25-16Reiterated Barrington Research Outperform $14 → $15.50
Feb-08-16Upgrade Sidoti Neutral → Buy
Jan-20-16Initiated Sidoti Neutral
Dec-07-15Reiterated ROTH Capital Buy $15 → $18
Dec-07-15Reiterated Dougherty & Company Buy $16 → $19
Dec-04-15Reiterated Stifel Buy $14 → $17
Oct-28-15Upgrade Barrington Research Mkt Perform → Outperform $14
Sep-10-15Initiated Barrington Research Mkt Perform
Jul-29-15Reiterated The Benchmark Company Buy $12 → $14
Jul-29-15Reiterated ROTH Capital Buy $11 → $14
Jul-29-15Reiterated Brean Capital Buy $11 → $13
Jun-19-15Initiated Dougherty & Company Buy $14
Jun-24-14Initiated Stifel Buy $11
May-19-14Initiated Brean Capital Buy $11
Jul-14-17 03:23PM  ETFs with exposure to LeMaitre Vascular, Inc. : July 14, 2017 Capital Cube
Jul-13-17 04:15PM  LeMaitre Vascular Will Announce Second Quarter 2017 Earnings Results on July 27, 2017 GlobeNewswire
Jul-11-17 09:14AM  LeMaitre Vascular, Inc. breached its 50 day moving average in a Bearish Manner : LMAT-US : July 11, 2017 Capital Cube
Jul-10-17 04:44PM  Why Macy's, Cincinnati Bell, and LeMaitre Vascular Slumped Today Motley Fool -12.66%
Jul-03-17 03:24PM  ETFs with exposure to LeMaitre Vascular, Inc. : July 3, 2017 Capital Cube
Jun-26-17 08:39AM  LeMaitre Vascular, Inc. breached its 50 day moving average in a Bullish Manner : LMAT-US : June 26, 2017 Capital Cube
Jun-19-17 12:00PM  LeMaitre Vascular, Inc. :LMAT-US: Earnings Analysis: Q1, 2017 By the Numbers : June 19, 2017 Capital Cube
Jun-15-17 04:23PM  LeMaitre Vascular, Inc. Value Analysis (NASDAQ:LMAT) : June 15, 2017 Capital Cube
02:27PM  ETFs with exposure to LeMaitre Vascular, Inc. : June 15, 2017 Capital Cube
Jun-14-17 08:41AM  LeMaitre Vascular, Inc. breached its 50 day moving average in a Bearish Manner : LMAT-US : June 14, 2017 Capital Cube
May-15-17 08:55AM  Time to Focus on LeMaitre Vascular (LMAT) for Strong Earnings Growth Potential Zacks
May-11-17 04:15PM  LeMaitre Vascular to Present at Upcoming Investor Conferences GlobeNewswire
08:23AM  7 Stocks to Buy with Impressive Interest Coverage Ratio Zacks
May-09-17 04:48AM  Can The Uptrend Continue for LeMaitre Vascular (LMAT)? Zacks
May-05-17 01:05PM  Edited Transcript of LMAT earnings conference call or presentation 26-Apr-17 9:00pm GMT Thomson Reuters StreetEvents
May-01-17 06:08PM  LeMaitre Vascular Set to Join S&P SmallCap 600 PR Newswire
Apr-28-17 02:16PM  LeMaitre Vascular, Inc.: Leads amongst peers with strong fundamentals Capital Cube -6.62%
11:29AM  Diagnostic Kit Maker Tests Resistance In Base; Gets Rating Upgrade Investor's Business Daily
09:40AM  Top Ranked Momentum Stocks to Buy for April 28th Zacks
Apr-27-17 12:45PM  Here's Why LeMaitre Vascular Stock Is Soaring Today Motley Fool +20.77%
Apr-26-17 06:02PM  LeMaitre tops Street 1Q forecasts Associated Press
04:05PM  LeMaitre Q1 2017 Record Sales $24.1 mm (+19%), Net Income $3.2 mm (+49%) GlobeNewswire
Apr-18-17 01:00PM  Medical Device Stocks to Beat Estimates this Earnings Season Zacks
Apr-12-17 04:15PM  LeMaitre Vascular Will Announce First Quarter 2017 Earnings Results on April 26, 2017 GlobeNewswire
Mar-31-17 09:00AM  LeMaitre Vascular to Present at the 16th Annual Needham Healthcare Conference on Tuesday, April 4, 2017 GlobeNewswire
Mar-23-17 04:15PM  LeMaitre Vascular to Present at the Sidoti & Company Spring 2017 Convention on Wednesday, March 29, 2017 GlobeNewswire
Mar-21-17 05:54AM  Coverage initiated on Lemaitre Vascular by First Analysis Sec
Mar-14-17 01:04PM  LEMAITRE VASCULAR INC Financials
Mar-09-17 04:05PM  LeMaitre Vascular to Present at the Barclays Global Healthcare Conference on Tuesday, March 14, 2017 GlobeNewswire
Mar-08-17 04:05PM  LeMaitre Vascular to Present at the 29th Annual ROTH Conference on Tuesday, March 14, 2017 GlobeNewswire
Mar-01-17 04:20PM  LeMaitre Vascular to Present at the Cowen & Company 37th Annual Health Care Conference on March 6, 2017 GlobeNewswire
Feb-23-17 04:15PM  LeMaitre Vascular to Participate in 2017 BTIG Medical Technology, Life Science and Diagnostic Tools Conference on Wednesday, March 1, 2017 GlobeNewswire
12:58PM  LeMaitre Vascular, Inc. :LMAT-US: Earnings Analysis: 2016 By the Numbers : February 23, 2017 Capital Cube
12:58PM  LeMaitre Vascular, Inc. :LMAT-US: Earnings Analysis: 2016 By the Numbers : February 23, 2017
11:08AM  LeMaitre Vascular, Inc. :LMAT-US: Earnings Analysis: Q4, 2016 By the Numbers : February 23, 2017
Feb-21-17 05:04PM  LeMaitre misses Street 4Q forecasts Associated Press
04:14PM  LEMAITRE VASCULAR INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
04:05PM  LeMaitre Q4 2016 Record Sales $23.3 mm (+14%), Op. Income $3.9 mm (+27%) GlobeNewswire
07:07AM  Q4 2016 LeMaitre Vascular Inc Earnings Release - After Market Close
Feb-07-17 04:15PM  LeMaitre Vascular Will Announce Fourth Quarter 2016 Earnings Results on February 21, 2017 GlobeNewswire
Feb-06-17 08:30AM  LeMaitre Vascular, Inc. Presentation Now Available for On-Demand Viewing PR Newswire
Jan-31-17 04:01PM  LeMaitre Vascular, Inc. to Webcast, Live, at VirtualInvestorConferences.com February 2 PR Newswire
Jan-30-17 02:16PM  Life Sciences & Healthcare Investor Conference & Webinar: Nasdaq and OTCQX Companies Present February 2nd PR Newswire
Jan-20-17 10:20AM  LeMaitre Vascular, Inc. : LMAT-US: Dividend Analysis : November 21st, 2016 (record date) : By the numbers : January 20, 2017
Jan-19-17 11:00AM  LeMaitre Vascular, Inc. Value Analysis (NASDAQ:LMAT) : January 19, 2017
Jan-18-17 09:44AM  LeMaitre Vascular, Inc. breached its 50 day moving average in a Bearish Manner : LMAT-US : January 18, 2017
Jan-05-17 04:15PM  LeMaitre Vascular to Present at the Needham Growth Conference on Thursday, January 12, 2017 GlobeNewswire
Jan-03-17 02:26PM  ETFs with exposure to LeMaitre Vascular, Inc. : January 3, 2017
Dec-13-16 03:54AM  How LeMaitre Vascular Inc (LMAT) Stacks Up Against Its Peers at Insider Monkey
Dec-07-16 04:05PM  LeMaitre Vascular to Participate in the Guggenheim Securities 4th Annual Boston Healthcare Conference on Tuesday, December 13, 2016 GlobeNewswire
Nov-29-16 01:30PM  LeMaitre Vascular to Participate in the Benchmark Micro Cap Discovery Conference on Thursday, December 1, 2016 GlobeNewswire
Nov-14-16 08:03AM  LEMAITRE VASCULAR INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
08:02AM  LeMaitre (LMAT) Hits a 52-Week High on Strategic Buyout
Nov-11-16 08:53AM  LeMaitre Vascular Buys Restore Flow Allografts for $14M
Nov-10-16 05:23PM  LEMAITRE VASCULAR INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Di
05:15PM  LeMaitre Vascular Acquires Restore Flow Allografts GlobeNewswire
Nov-08-16 04:15PM  LeMaitre Vascular to Present at Three Investor Conferences in November GlobeNewswire
Nov-04-16 12:57PM  LEMAITRE VASCULAR INC Files SEC form 10-Q, Quarterly Report
Nov-01-16 10:42AM  Is LeMaitre Vascular (LMAT) Great Growth Stock?
Oct-31-16 01:48PM  ETFs with exposure to LeMaitre Vascular, Inc. : October 31, 2016
Oct-28-16 04:17PM  LeMaitre Vascular, Inc.: Leads amongst peers with strong fundamentals
11:37AM  LeMaitre Vascular, Inc. :LMAT-US: Earnings Analysis: Q3, 2016 By the Numbers : October 28, 2016
09:41AM  LeMaitre Vascular, Inc. breached its 50 day moving average in a Bullish Manner : LMAT-US : October 28, 2016
Oct-26-16 05:51PM  LeMaitre tops Street 3Q forecasts
04:24PM  LEMAITRE VASCULAR INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Princ
04:05PM  LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%) GlobeNewswire
07:07AM  Q3 2016 LeMaitre Vascular Inc Earnings Release - After Market Close
Oct-25-16 03:20PM  LeMaitre Vascular to Present at the Sidoti & Company Fall 2016 Emerging Growth Convention on November 1, 2016 GlobeNewswire
Oct-19-16 12:43PM  ETFs with exposure to LeMaitre Vascular, Inc. : October 19, 2016
Oct-18-16 04:08PM  LeMaitre Vascular Will Announce Third Quarter 2016 Earnings Results on October 26, 2016 GlobeNewswire
08:33AM  LeMaitre Vascular, Inc. breached its 50 day moving average in a Bearish Manner : LMAT-US : October 18, 2016
Oct-17-16 12:37PM  LeMaitre Vascular, Inc. : LMAT-US: Dividend Analysis : August 22nd, 2016 (record date) : By the numbers : October 17, 2016
Oct-11-16 04:00PM  Can This Top Medical Stock Recuperate From Market Sell-Off?
Sep-20-16 03:03PM  LeMaitre Vascular to Participate in the Dougherty & Co. Institutional Investor Conference on September 28, 2016 GlobeNewswire
09:00AM  Is LeMaitre Vascular (LMAT) a Great Growth Stock?
08:52AM  Can the Rally in LeMaitre Vascular (LMAT) Shares Continue?
Sep-14-16 10:18AM  ETFs with exposure to LeMaitre Vascular, Inc. : September 14, 2016
08:49AM  LeMaitre Hits 52-Week High on Strong International Presence
Sep-12-16 08:52AM  3 Reasons Why LeMaitre Vascular (LMAT) is a Great Momentum Stock
Aug-25-16 05:43PM  LeMaitre Vascular to Attend the 9th Annual Barrington Research Fall Investment Conference on September 8, 2016 GlobeNewswire
Aug-22-16 11:40AM  ETFs with exposure to LeMaitre Vascular, Inc. : August 22, 2016
Aug-16-16 04:33PM  LeMaitre Vascular to Participate in the Midwest IDEAS Investor Conference on August 30, 2016 GlobeNewswire
11:31AM  Moving Average Crossover Alert: LeMaitre Vascular (LMAT)
Aug-11-16 02:33AM  Will LeMaitre Vascular (LMAT) Continue to Surge Higher?
Aug-05-16 12:03PM  LEMAITRE VASCULAR INC Files SEC form 10-Q, Quarterly Report
11:18AM  LeMaitre Vascular, Inc. :LMAT-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016
Aug-02-16 04:39PM  CVS Health (CVS) Tops Q2 Earnings, Lags on Revenue, View Up
04:36PM  Omnicell (OMCL) Tops Q2 Earnings & Revenues, Margins Drag
04:26PM  LeMaitre Vascular to Participate in the Canaccord Genuity 36th Annual Growth Conference on August 11, 2016 GlobeNewswire
Aug-01-16 03:44PM  Edited Transcript of LMAT earnings conference call or presentation 27-Jul-16 9:00pm GMT
Jul-29-16 04:29PM  LeMaitre Vascular, Inc.: Leads amongst peers with strong fundamentals
Jul-27-16 07:10PM  LeMaitre beats Street 2Q forecasts
05:00PM  LeMaitre Vascular Inc Earnings Call scheduled for 5:00 pm ET today
04:15PM  LEMAITRE VASCULAR INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Stat
04:05PM  LeMaitre Q2 2016 Record Sales $22.4mm (+13%), Record Op. Income $3.8mm (+35%) GlobeNewswire
07:07AM  Q2 2016 LeMaitre Vascular Inc Earnings Release - After Market Close
Jul-26-16 01:04PM  Why Cryolife Inc's Shares Turned Hot Today at Motley Fool
Jul-19-16 03:37PM  LeMaitre Vascular Will Announce Second Quarter 2016 Earnings Results on July 27, 2016 GlobeNewswire
Jun-29-16 08:25AM  Medtronic Positive on HeartWare Buy, Covidien Synergies
Jun-22-16 08:26AM  Walgreen Boots Hopeful on Rite Aid Buyout amid Margin Woes
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. The company provides angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; carotid shunts to temporarily divert or shut blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and powered phlebectomy devices that enable removal of varicose veins. It also offers embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude blood flow; and perfusion catheters that temporarily perfuse blood and other liquids into the vasculature. In addition, the company provides radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin; and remote endarterectomy devices to remove plaque from arteries in the leg. Further, it offers valvulotomes that cuts valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; vascular grafts to bypass or replace diseased arteries; vascular patches, which are used for precision endarterectomy vascular reconstruction; vessel closure systems to attach vessels to one another with titanium clips instead of sutures; and laparoscopic cholecystectomy devices to inject dye into the cystic duct during laparoscopic cholecystectomy, as well as laparoscopic accessory for use in laparoscopic gall bladder removal. LeMaitre Vascular, Inc. markets its products through direct and indirect sales force. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
O'Connor John JamesDirectorJul 10Option Exercise6.237,50046,72580,480Jul 12 04:44 PM
LeMaitre George WChairman and CEOJun 26Option Exercise6.8518,271125,1563,393,341Jun 28 05:09 PM
Roberts David BPresident and DirectorJun 05Option Exercise7.0621,605152,49629,019Jun 07 04:02 PM
Wijas Michael TVP of Sales, The AmericasJun 01Option Exercise12.762,34629,9353,584Jun 02 04:27 PM
Wijas Michael TVP of Sales, The AmericasJun 01Sale31.422,34673,7171,238Jun 02 04:27 PM
Kamke Trent GSenior V. P., OperationsMay 24Option Exercise7.1013,73397,50431,341May 26 05:38 PM
Kamke Trent GSenior V. P., OperationsMay 24Sale30.2815,780477,82215,561May 26 05:38 PM
LeMaitre George WChairman and CEOMay 18Sale29.4910,000294,9383,375,070May 18 08:47 PM
LeMaitre George WChairman and CEOMay 17Sale30.261,22537,0693,385,070May 18 08:47 PM
LeMaitre George WChairman and CEOMay 16Sale30.7210,000307,1693,386,295May 18 08:47 PM
Roberts David BPresident and DirectorMay 11Sale30.3739,5311,200,6797,414May 12 04:09 PM
LeMaitre George WChairman and CEOMay 10Sale31.4520,003629,1163,396,295May 10 07:11 PM
LeMaitre George WChairman and CEOMay 09Sale30.6734,5171,058,6953,416,298May 10 07:11 PM
LeMaitre George WChairman and CEOMay 08Sale31.129,102283,2193,450,815May 10 07:11 PM
Roberts David BPresident and DirectorMay 04Option Exercise5.8522,980134,43369,925May 05 04:02 PM
Roberts David BPresident and DirectorMay 04Sale31.2022,980717,00646,945May 05 04:02 PM
Roberts David BPresident and DirectorMay 03Sale31.0721,360663,59546,945May 05 04:02 PM
LeMaitre George WChairman and CEOMay 03Sale31.3824,232760,2963,459,917May 04 05:29 PM
LeMaitre George WChairman and CEOMay 02Sale32.7810,000327,80272,030May 04 05:29 PM
LeMaitre George WChairman and CEOMay 02Sale32.7253,1101,737,8283,484,149May 04 05:29 PM
Roberts David BPresident and DirectorApr 25Option Exercise5.8521,360124,95668,305Apr 26 04:39 PM
LeMaitre George WChairman and CEOApr 24Option Exercise9.7485,565833,3513,537,259Apr 26 04:35 PM
Roberts David BPresident and DirectorMar 10Sale22.445,900132,38046,945Mar 10 04:14 PM
LeMaitre George WChairman and CEOMar 01Sale22.602,00045,20582,030Mar 01 08:32 PM
LeMaitre George WChairman and CEOFeb 28Sale22.273,00066,82484,030Mar 01 08:32 PM
LeMaitre George WChairman and CEOFeb 27Sale22.315,000111,53787,030Mar 01 08:32 PM
LeMaitre George WChairman and CEOFeb 22Option Exercise7.2273,631531,4993,451,694Feb 24 05:53 PM
Roberts David BPresident and DirectorNov 17Sale24.6420,000492,89052,845Nov 21 04:53 PM
Gebauer Peter RPresident, International OPNov 16Sale23.7812,943307,8442,431Nov 18 04:00 PM
Roberts David BPresident and DirectorOct 13Option Exercise4.553,05213,89472,845Oct 17 04:30 PM
Roberts David BPresident and DirectorSep 16Sale21.056,452135,82969,793Sep 20 04:14 PM
Roberts David BPresident and DirectorSep 15Sale21.023,54874,59176,245Sep 16 04:30 PM
Roberts David BPresident and DirectorSep 14Sale20.3330,000609,99979,793Sep 16 04:30 PM
LeMaitre George WChairman and CEOSep 08Sale20.5920,000411,8023,375,063Sep 08 05:42 PM
Roberts David BPresident and DirectorSep 07Sale20.7710,000207,678109,793Sep 08 05:49 PM
Gebauer Peter RPresident, International OPSep 06Sale20.0810,000200,79515,374Sep 08 05:51 PM
Roberts David BPresident and DirectorSep 06Sale19.3610,000193,624119,793Sep 08 05:49 PM
LeMaitre George WChairman and CEOSep 06Sale20.2410,000202,4483,395,063Sep 08 05:42 PM
LeMaitre George WChairman and CEOSep 02Sale18.2338,035693,3673,405,063Sep 02 09:30 PM
LeMaitre George WChairman and CEOAug 31Sale18.4222,002405,2003,443,098Sep 02 09:30 PM
Gebauer Peter RPresident, International OPAug 30Option Exercise11.433,43139,21628,805Aug 31 05:32 PM
Gebauer Peter RPresident, International OPAug 30Sale18.203,43162,44425,374Aug 31 05:32 PM
Gebauer Peter RPresident, International OPAug 29Option Exercise7.4126,815198,69752,189Aug 31 05:32 PM
Gebauer Peter RPresident, International OPAug 29Sale17.7826,815476,76325,374Aug 31 05:32 PM
LeMaitre George WChairman and CEOAug 24Sale17.496,800118,9433,465,100Aug 24 08:51 PM
Roberts David BPresident and DirectorAug 24Sale17.285,00086,405129,793Aug 25 09:15 AM
Roberts David BPresident and DirectorAug 23Sale17.425,00087,123134,793Aug 25 09:15 AM
LeMaitre George WChairman and CEOAug 23Sale17.4319,664342,7303,471,900Aug 24 08:51 PM
LeMaitre George WChairman and CEOAug 22Sale17.398,927155,2803,491,564Aug 24 08:51 PM
LeMaitre Cornelia WDirectorAug 19Sale17.155,00085,733178,319Aug 22 09:04 AM
LeMaitre Cornelia WDirectorAug 18Sale17.367,500130,199183,319Aug 18 06:52 PM
LeMaitre Cornelia WDirectorAug 17Sale17.347,500130,021190,819Aug 18 06:52 PM
LeMaitre Cornelia WDirectorAug 16Sale17.397,500130,418198,319Aug 18 06:52 PM
LeMaitre George WChairman and CEOAug 15Sale17.5012,348216,0333,500,491Aug 15 06:58 PM
LeMaitre Cornelia WDirectorAug 15Sale17.417,500130,576205,819Aug 15 07:01 PM
LeMaitre Cornelia WDirectorAug 12Sale17.237,500129,257213,319Aug 15 07:01 PM
LeMaitre George WChairman and CEOAug 11Sale17.633,54862,5493,512,839Aug 15 06:58 PM
LeMaitre Cornelia WDirectorAug 11Sale17.437,500130,727220,819Aug 15 07:01 PM
Jasinski Lawrence JDirectorAug 09Option Exercise8.667,50064,92517,863Aug 11 08:44 AM
Jasinski Lawrence JDirectorAug 09Sale17.607,500132,00110,363Aug 11 08:44 AM
LeMaitre George WChairman and CEOAug 09Sale17.542,16037,89692,030Aug 09 09:10 PM
LeMaitre George WChairman and CEOAug 08Sale17.261,80031,06994,190Aug 09 09:10 PM
Roberts David BPresident and DirectorAug 05Sale17.462003,492139,793Aug 05 04:11 PM
LeMaitre George WChairman and CEOAug 05Sale17.401,50026,09395,990Aug 09 09:10 PM
LeMaitre George WChairman and CEOAug 04Sale17.692,10037,13997,490Aug 04 05:38 PM
Roberts David BPresident and DirectorAug 04Sale17.615008,803139,993Aug 05 04:11 PM
Roberts David BPresident and DirectorAug 03Sale17.649,300164,037140,493Aug 05 04:11 PM
LeMaitre George WChairman and CEOAug 03Sale17.642,00035,28999,590Aug 04 05:38 PM
LeMaitre George WChairman and CEOAug 02Sale17.494407,696101,590Aug 04 05:38 PM
Gebauer Peter RPresident, International OPJul 28Sale16.4730,000494,16925,374Aug 01 04:30 PM